Yesterday, various U.S. federal bodies announced psychedelics-related actions, as we covered. That news included a funding award from the National Institute on Drug Abuse (NIDA) to support a multi-phase ibogaine for opioid use disorder (OUD) project at Harvard. The Advanced Research Projects Agency for Health (ARPA-H) also announced a funding opportunity related to developing ibogaine for OUD…
